MOLECULAR-BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY

被引:154
|
作者
AREVALO, JH
TAUSSIG, MJ
WILSON, IA
机构
[1] SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA
[2] AFRC, BABRAHAM INST, DEPT IMMUNOL, STRUCT STUDIES LAB, CAMBRIDGE CB2 4AT, ENGLAND
关键词
D O I
10.1038/365859a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
TWO major unanswered questions concerning the specificity of antibodies are: how do structurally different antigens bind with high affinity to the same antibody, and what are the limits of the antibody combining site complementarity and flexibility that contribute to such crossreactivity? We report here a comparative analysis of the X-ray structures of five conformationally different steroids in complex with the Fab' fragment of an anti-progesterone antibody DB3 at 2.7 angstrom. This antibody is unable to complement completely the shape of the hydrophobic antigen so that crossreactivity occurs with other ligands without major structural rearrangements of the binding site. Antigen specificity can be explained through conserved interactions of DB3 with the steroid D-ring, whereas some of the crossreactivity is realized through different binding orientations of the steroid skeleton that place the A-ring into alternative pockets on the antibody surface. The restricted gene usage of the VGAM3.8 family in the generation of anti-progesterone monoclonal antibodies1,2 may be explained by the specific interaction Of V(H) hallmark residues with the steroid D-ring. This first detailed structure of steroid interactions with a protein could be applied to the understanding of general mechanisms of steroid recognition as well as in the design of specific binding sites for small hydrophobic ligands.
引用
收藏
页码:859 / 863
页数:5
相关论文
共 50 条
  • [41] Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin
    Garcia-Rodriguez, Consuelo
    Levy, Raphael
    Arndt, Joseph W.
    Forsyth, Charles M.
    Razai, Ali
    Lou, Jianlong
    Geren, Isin
    Stevens, Raymond C.
    Marks, James D.
    NATURE BIOTECHNOLOGY, 2007, 25 (01) : 107 - 116
  • [42] LACK OF RADIOIMMUNODETECTION AND COMPLICATIONS ASSOCIATED WITH MONOCLONAL ANTICARCINOEMBRYONIC ANTIGEN-ANTIBODY CROSS-REACTIVITY WITH AN ANTIGEN ON CIRCULATING CELLS
    DILLMAN, RO
    BEAUREGARD, JC
    SOBOL, RE
    ROYSTON, I
    BARTHOLOMEW, RM
    HAGAN, PS
    HALPERN, SE
    CANCER RESEARCH, 1984, 44 (05) : 2213 - 2218
  • [43] Cross-docking to identify antibody-antigen interaction partners
    Kilambi, Krishna Praneeth
    Gray, Jeffrey J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [44] MOLECULAR-BASIS OF SURFACE-ANTIGEN VARIATION IN NEISSERIA
    MEYER, TF
    TRENDS IN GENETICS, 1987, 3 (11) : 319 - 324
  • [45] Molecular and Structural Basis of Cross-Reactivity inM. tuberculosisToxin-Antitoxin Systems
    Tandon, Himani
    Vattekatte, Akhila Melarkode
    Srinivasan, Narayanaswamy
    Sandhya, Sankaran
    TOXINS, 2020, 12 (08)
  • [46] THE MOLECULAR BASIS OF LOA LOA CROSS-REACTIVITY IN THE RAPID DIAGNOSTIC TEST FOR LYMPHATIC FILARIASIS
    Hertz, Marla
    Rush, Amy
    Wanji, Samuel
    Weil, Gary
    Budge, Philip
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 162 - 162
  • [47] A structural basis for food allergy: the role of cross-reactivity
    Bonds, Rana S.
    Midoro-Horiuti, Terumi
    Goldblum, Randall
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 8 (01) : 82 - 86
  • [48] MOLECULAR-BASIS OF SURFACE-ANTIGEN VARIATION IN PARAMECIA
    CARON, F
    MEYER, E
    ANNUAL REVIEW OF MICROBIOLOGY, 1989, 43 : 23 - 42
  • [49] MOLECULAR-BASIS OF ANTIGEN MIMICRY BY AN ANTI-IDIOTOPE
    FIELDS, BA
    GOLDBAUM, FA
    YSERN, X
    POLJAK, RJ
    MARIUZZA, RA
    NATURE, 1995, 374 (6524) : 739 - 742
  • [50] Specificity and cross-reactivity of Plasmodium falciparum variant surface antigen-specific antibody responses
    Hviid, L
    Staalsoe, T
    Nielsen, MA
    Theander, TG
    INFECTION AND IMMUNITY, 2003, 71 (04) : 2296 - 2296